Back to search
FDAFDA · Food and drugs·Recall number D-0619-2026

hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10

Published July 1, 2026 · Recall initiated: June 2, 2026

Summary

FDA records drug Class III recall D-0619-2026, published July 1, 2026 and initiated June 2, 2026. Recalling firm: ANI Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 6564 bottles; Lot: Lot S25133A. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of foreign substance

What to do

Voluntary: Firm initiated · Letter

Get an email if HYDROXYZINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
HYDROXYZINE HYDROCHLORIDE
Manufacturer
ANI Pharmaceuticals, Inc.
Distributor
Nationwide in the USA
UPC
0370954912101
Lot
Lot S25133A
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10 recalled?

Yes. FDA published recall D-0619-2026 on July 1, 2026. Reported hazard: Presence of foreign substance

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: HYDROXYZINE HYDROCHLORIDE. UPC: 0370954912101.